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Introduction
Solid dosage forms such as tablets and capsules are the most stable 
dosage form for drug delivery. They are more capable of maintaining 
the stability of an active pharmaceutical ingredient (API) over its shelf 
life when compared to liquid or semi-solid dosage forms. The solid 
dosage forms, in addition, permit the delivery of an accurate dose of an 
API to its active site in the body. Because of these properties, they are 
now economically mass produced and currently dominated the global 
drug market [1,2]. 
A tablet is a solid dosage form that is manufactured using Direct 
compression (DC) or wet granulation method. The DC method has been 
considered the simplest and most economical method of manufacturing 
tablets. It is thus, widely used because it requires less processing steps 
[3]. Despite its advantages, very few excipients are available for use 
in DC due to stringent requirements of compatibility, safety and 
stability. During the compaction process, the deformation mechanism 
of pharmaceutical powders used in formulating directly compressed 
tablets affects the physicomechanical characteristics of the tablets 
formed. The properties of the resulting compact can be influenced by 
the presence of a lubricant and binder since pharmaceutical materials 
normally consolidate by more than one mechanisms [4]. However, in 
pharmaceutical powder technology, the global models of Heckel and 
Kawakita have typically been the most frequently used [5].
In recent years, there is a rapid proliferation in the development 
of novel pharmaceutical excipients with enhanced functionality 
using particle engineering by processes such as physical or chemical 
modification and co-processing [6]. The versatility of native starch has 
made it the excipient of choice in many solid dosage forms. It has been 
successfully employed as tablet binder, disintegrant and filler in tablet 
formulations processed by wet granulation [6,7]. Native starches in their 
derivative forms open a wide scope in pharmaceutical applications. 
However, it has limited usage in DC due to its inherent weaknesses 
of poor flow and compressibility properties. The poor functionality 
of native starches could be attributed to its particle properties such as 
particle shape, size and particle size distribution that further constituted 
the bulk properties of the starch. Thus, this prompted researchers 
to embark on developing various methods of producing modified 
forms of starches that will enhance their functionality in tabletting 
technology. This study therefore serves to provide alternative sources 
for directly compressible excipients from locally available source for 
use in tableting.
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Abstract
Wet and dry granulation methods for tablet manufacturing tend to be problematic for thermolabile and moisture 
sensitive drugs, and few excipients are available for use in direct compression (DC) due to stringent requirements. 
This study aimed to evaluate the drug/excipients compatibility, compaction and in vitro dissolution properties of 
Plectranthus esculentus modified starches in tablets using metronidazole as a model drug by DC. Native starch 
extracted from P. esculentus was modified by three methods and we produced three modified starches namely; 
acid hydrolyzed P. esculentus starch (APS), pregelatinized P. esculentus starch (PPS), and ethanol dehydrated 
pregelatinized P. esculentus starch (PPE). For drug/excipient compatibility studies, Fourier Transform Infrared 
Spectroscopy (FTIR) was used. Powder compaction was evaluated using Heckel model, while in vitro dissolution 
studies were conducted using USP basket method. The starches were evaluated in comparison with microcrystalline 
cellulose (MCC PH 101). The FTIR peaks revealed no interaction of these excipients with the drug. Compaction 
studies indicate that the modifications yielded starches of comparable compact behaviors with MCC PH 101 
especially APS and PPE, they both plastically deformed with PPE producing the hardest tablets. APS and PPS 
disintegrate faster 2.83 and 1.42 min respectively which were significantly different from the disintegration time of 
MCC PH 101 and PPE which are higher 35.34 and 45.53 min respectively. For the in vitro dissolution, APS and PPS, 
their T50 and T90 were achieved in less than 10 min, T50 and T90 for PPE were achieved at 38 and 58 min respectively, 
while for MCC PH 101 both T50 and T90 were not observed after 60 min. APS produced metronidazole tablets of 
better quality in terms crushing strength, friability and drug-release profile. Acid hydrolysis of P. esculentus starch 
produced good directly compressible excipient that can be use in DC for immediate release tablet formulations.
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In the current study, we aimed to develop modified forms of 
starches from a local source of starch in Nigeria, Plectranthus esculentus 
popularly known as Livingstone potato, is an indigenous tuber cultivated 
locally in some parts of Nigeria and tropical Africa. It is cultivated in 
the Upper Niger valley of the Hausa land in Nigeria and in the Central 
African Republic [8]. The tuber is rich in carbohydrate, which forms 
more than 80% of its constituents used mostly as a staple food by locals. 
Metronidazole is a medium dose drug and poorly compressible due 
to its crystalline nature [9]. Furthermore, we use metronidazole as a 
model drug because of its inherent poor compressibility nature.
The objectives of this study were to (i) evaluate the compatibility 
of the modified starches developed from the P. esculentus with 
Metronidazole as an API using FTIR, (ii) conduct powder compaction 
studies using Heckel model and (iii) produce tablets using 
metronidazole as a model drug by DC. 
Materials and Methods
Materials 
Plectranthus esculentus starch powder was extracted from the 
tubers obtained from Vom, Plateau state, Nigeria. Metronidazole 
powder (BDH Chemicals Ltd Poole, England), microcrystalline 
cellulose PH 101 (ATOZ Pharmaceuticals Ltd, Ambattur, India), stearic 
acid (BDH Chemicals Ltd Poole, England), talc (BDH Chemicals Ltd 
Poole, England), absolute Ethanol (Emerck Darmstadt, Germany), 
Hydrochloric acid HCl (Emerck Darmstadt, Germany), xylene (Loba 
Chemic Laboratory Ltd, Mumbai India), sodium hydroxide pellets 
(Avondale Laboratories Ltd, Banbury, England) and glycerol (BDH 
Chemicals Ltd Poole, England).
Methods
Collection, identification and extraction of Plectranthus 
esculentus starch: Fresh tubers of Plectranthus esculentus were brought 
to the Process Laboratory of the Department of Pharmaceutics and 
Pharmaceutical Microbiology of Ahmadu Bello University, Zaria, 
washed, peeled and grated. The grates were washed, weighed, and 
then ground to a fine pulp using grinding machine. Calico cloth was 
used to sieve the starch from other impurities. The starch in the excess 
water was allowed to settle overnight. Little quantities of 0.1N NaOH 
solution were added and stirred for 10 minutes to dissolve the protein 
contents. The suspension was then centrifuged at 1000 rpm for 10 
minutes. The starch obtained was spread on stainless steel trays and 
air-dried for 24 hours and then dried at 400C for one hour. The dried 
starch was size-reduced to a fine powder (90-250 µm) using mortar and 
pestle. It was weighed and percentage yield determined. This was then 
packed in a polyethylene bag, labelled and stored at room temperature 
until required. 
Preparation of acid-hydrolyzed Plectranthus esculentus starch: 
Modified procedures of Wang et al., for acid hydrolysis of starch and 
the method in the Pharmaceutical Codex were adopted [10,11]. Three 
hundred grams (300 g) of the native starch powder was suspended in 
800 mL of distilled water. The reaction was initiated by adding 28 mL of 
6 N HCl into the suspension, stirred and placed on digital thermostatic 
water bath set at 520C. The reaction was allowed to proceed for 24 
hours while stirring intermittently. An equal volume of distilled water 
was added at room temperature and centrifuged at 1000 rpm for 10 
minutes. The pH was then adjusted with 1 N NaOH, sufficient quantity 
of distilled water was added again and then dehydrated with 95% 
ethanol. Hydrolyzed starch was spread on a stainless-steel tray and air 
dried for 24 hours, then dried in hot air oven (BS size 3 Gallenkamp, 
England) at 400C for 1 hour. The sample was then passed through 125 
µm mech, packed in air-tied container and labelled as acid hydrolyzed 
P. esculentus starch (APS). 
Preparation of pregelatinized P. esculentus starch/determination 
of gelatinization temperature: Pregelatinized starches were prepared 
according to method described by Adedokun and Itiola 2010 [12], 
with some modifications. Briefly, one hundred and fifty grams (150 g) 
of the native starch powder was suspended in 1 L of distilled water at 
room temperature. The suspension was placed in a water bath (Digital 
thermostatic water bath) set at 900C and stirred continuously until it 
begins to gelatinize at 660C. The mucilage was then thinly spread on 
stainless steel trays and dried in hot air oven (BS size 3 Gallenkamp, 
England) at 600C for 24 hours. The dried flakes were milled using 
laboratory blender. The pulverized powder was passed through 125 µm 
mech size, this was labelled pregelatinized P. esculentus starch (PPS) and 
packed in air-tied container until need. This procedure was repeated 
but instead of drying directly, absolute ethanol was used to dehydrate 
the starch, and then dried at 400C for 24 hours, milled and labelled as 
ethanol dehydrated pregelatinized P. esculentus starch (PPE).
Determination of bulk and tapped densities: Ten grams (10 g) 
of each starch powder was placed in a 50 mL measuring cylinder and 
the bulk volume noted. After several taps to a constant volume (rising 
to about 10 cm height), the volume was noted. The bulk density (BD) 
and tapped density (TD) were then calculated. The Carr’s index (C.I) 
and Hausner’s ratio (H.R) were also calculated using Wells and Aulton 
[13] equations:
Carr’s Index (C.I) = T.D -B.D/T.D x 100
Hausner’s ratio (H.R) = T.D/B.D
Determination of true density: The true densities (Dt), of each 
starch samples were determined by the liquid displacement method 
using xylene as the immersion fluid and computed according to the 
following equation:
Dt = Wp [(a + Wp) – b] x SG
Where, Wp is the weight of powder, SG is specific gravity of solvent 
(xylene, 0.86), a is weight of bottle + solvent and b is weight of bottle + 
solvent + powder.
Determination of packing fraction and porosity: The packing 
fraction (Pf) was expressed as the ratio between the bulk density (BD) 
and the true density (Dt): 
Pf = B.D/Dt 
Porosity = 1- B.D/Dt x 100
Determination of angle of repose: Twenty grams (20 g) of each 
starch sample was poured inside a glass funnel of orifice diameter 0.8 
cm clamped at height 10 cm from the table surface and was allowed to 
flow freely. The angle of repose, Ɵ was calculated from the equation:
ϴ = Tan-1 h/r
Where h = height of heap and r is the radius formed by the heap. It 
was repeated thrice and the mean ± SEM determined. 
Determination of flows rate: Twenty grams (20 g) each starch 
sample was placed in a flow rate machine (Type GD7, Erweka 
Apparatebau GMBH, Germany). The time of flow was note and the 
flow rate calculated in grams per second (g/s). The mean ± SEM of 
three determinations was calculated.
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The comparison was then made of these parameters for the different 
drug/excipients ratio to evaluate their dilution potentials using the 
method described by [6,9,14].
Tablet formulation: A batch size of 200 tablets was prepared, and 
four batches were made by direct compression using metronidazole as 
the active pharmaceutical ingredient (API). The target tablet weight 
was 550 mg as indicated in the formula for each batch in Table 1. 
The tablets were formulated by mixing the active drug and the filler/
binder in a mortar using a pestle to achieve a uniform blend for 10 
min. The calculated quantities of the glidant 0.75% w/w and lubricant 
0.25% w/w were weighed on an electronic scale and incorporated into 
the powder and mix for additional 2 min. Tablets were produced by 
direct compression using a single punch tabletting machine (Erweka-
AR400, Germany) fitted with 12 mm concave – faced punches and die 
set. Tablets were made at varying compression load between 3.5 – 9.5 
metric tons.
Weight uniformity test of tablets: Twenty tablets from each 
batch were selected at random and weighed individually using an 
electronic balance (MSI-A, Singapore). Their mean weights ±SEM 
were determined based on BP method.
Tablet disintegration test: The disintegration time was determined 
on six tablets in distilled water at 37°C ± 1°C according to the method 
described by USP (25) [15] using disintegration test unit (Erweka ZT3, 
Germany). The time taken for each tablet (n=6) to disintegrate and 
pass through the mesh was noted. The data for an average of 6 ± SEM 
determinations were recorded.
In vitro dissolution studies: The in vitro dissolution studies were 
conducted on the metronidazole tablet formulations using the USP 
basket apparatus [16] (DT, Erweka G.m.b.H. Germany) set at 100 rpm 
in 900 mL of dissolution medium (0.1 N HCl). The dissolution medium 
was maintained at 37 ± 0.5°C. Samples (5 mL) were withdrawn at 
different time intervals and replaced with the equivalent amount of 
fresh dissolution medium. The samples were diluted (1:9) with the 
dissolution medium prior to absorbance reading and the amount of 
metronidazole released was determined using UV spectrophotometer 
(Thermo-Biomate, England) at 277 nm. The percentage drug released 
was determined and plotted against time to generate dissolution 
profile data. A calibration curve was initially generated using standard 
metronidazole powder.
Assay of metronidazole (content uniformity): Five tablets were 
randomly selected from each batch, weighed and finely powdered 
using mortar and pestle. The weight of 550 mg equivalent to one tablet 
Flow Rate (Fr) = W/T
Where, W is the weight of the powder in grams (g) and T is the time 
taken for the powder to flow in seconds (s).
Determination of percentage moisture loss: Five grams (5 g) 
of each starch sample was heated in an oven (BS size 3 Gallenkamp, 
England) at 1050C, examined every hour until a constant weight was 
obtained. Percentage moisture loss was calculated as a ratio of loss in 
weight to the initial weight of the sample.
Determination of pH: One gram (1 g) of each starch sample was 
dispersed in 100 mL of distilled water and shaken for 5 minutes and 
allowed to stand for 10 minutes. The pH of the supernatant liquid was 
determined using pH meter (Oaklon pH 1100 series).
Microscopy and mean particle size determination: Little quantity 
of powdered sample was suspended in glycerol as mounting reagent on 
a slide and covered with a thin slit. The optical microscope (Olympus 
Optical Co., Japan) was first calibrated using eye-piece and stage 
micrometer respectively, set at X250 magnification. The prepared slides 
were viewed under the electronic optical microscope, and 500 particles 
were counted in each case and the mean projected particle diameter 
were determined which reflect the mean particle size.
Compaction studies and determination of compressibility 
index: Compacts of each powder sample were made by weighing 500 
mg individually and compressing at various compression loads ranging 
from 28.31 – 169.88 MNm-2 on Apex hydraulic hand press (Model 184, 
Apex Construction Ltd., London W.I and Dartford). The dwell time of 
30 seconds was allowed for each compression. Before the compression, 
the 10.5 mm die and flat-faced punches were lubricated with 2% w/v 
dispersion of magnesium stearate in acetone solution. After ejection, 
the compacts were stored in a desiccator over silica gel for 24 h to allow 
for elastic recovery and hardening and to prevent low yield values. 
The tablet weights (W) and dimensions (thickness and diameter) were 
then determined to within ± 1 mg and 0.01 mm respectively and their 
relative densities (D) were calculated using the following equation 
adopted from Apeji et al., [14]:
D = W/Vρs
Where V is the tablet volume (cm3) and ρs is the particle density (g/
cm3) of the solid material. Heckel plots of ln (1/1-D) against the applied 
pressure P (MNm-2). Compressibility index was determined using the 
plot of compact density (g/cm3) versus log compaction load in mega 
Newton per meter square (MNm-2).
Evaluation of dilution potential: 500 mg of the drug and excipients 
individually were mixed in the following proportions: 100:400, 
150:350, 200:300, 250:250 and 300:200 (mg). The binary blends were 
then compressed at varying compression loads on the single punch 
tableting machine (Erweka-AR400, Germany) at 400-500 MNm-2. The 
disintegration time of the tablets (n=6) was determined in distilled 
water at 37°C ± 1°C according to the method described by USP using 
disintegration test unit (Erweka ZT3, Germany). The crushing strength 
of the tablets (n=5) was determined using tablet hardness tester 
(Monsanto hardness tester, England) as the load required to cause 
diametral fracture of the tablet. The friability (Fr) of the compacts (n=5) 
was tested in tablet friabilitor (Type TA3R Erweka, Germany) operated 
at 25 rpm for 4 min. The fractional weight loss was computed as:
Fr = [mf – mi/mi] x 100 
where mi and mf are the initial and final tablet weight, respectively.
Ingredients Qty/tablet Qty/tablet (mg)
Qty/Batch of 200 
tablets (g)
Metronidazole (36.36%) 200 mg 200.00 40.00
Filler/binder: MCC PH 101, 
APS
PPE, PPS (62.64%)
q.s 244.50 68.90
Lubricant: stearic acid (% 
w/w) 0.25 1.38 0.28
Glidant: talc (%w/w) 0.75 4.13 0.83
Total 550 mg 550.00 110.00
q.s means quantity sufficient, Qty – quantity, MCC PH 101 – Microcrystalline 
cellulose,
APS – Acid hydrolyzed P. esculentus starch, PPS – Pregelatinized P. esculentus 
starch, PPE – Ethanol dehydrated pregelatinized P. esculentus starch. Batch size: 
200 tablets
Table 1: Tablet Formula for the formulation of modified starches of P. esculentus 
compared with MCC PH 101 in metronidazole tablet 200 mg.
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was dissolved in 100 mL of 0.1 N HCl. Tenfold dilution of the aliquots 
was further made, filtered and analyzed using UV spectrophotometer 
(Thermo-Biomate, England) for the content of metronidazole at 277 nm. 
Three determinations were made for each batch as specified by BP [17].
Determination of tablet diameter and thickness: Tablet thickness 
and diameter was measured using digital screw gauge micrometre 
(Moore and Wright Sheffield, England). A mean ± SEM of five 
determinations was obtained and recorded.
Friability test: The friability of ten (10) tablets was determined for 
each batch using Roche Friabilator (Type TA3R Erweka, Germany) 
operated at a rotation speed of 25 rpm for 4 minutes. The tablets 
were removed, dusted and re-weighed. Percentage of weight loss was 
determined using the formula described above. 
Determination of crushing strength: The crushing strength of 
tablets from each batch was determined using Monsanto hardness 
tester. The pressure was applied by turning the knob until the required 
pressure that crushed the tablet was read in terms of kilogram-force 
(kgf) on the scale, which was then converted to Newton (N). The results 
are presented as the mean of five (5) determinations.
Determination of tablet tensile strength: Tensile strength is the 
stress measured as force per unit area. It is the load required to fracture 
a tablet by diametrical compression. The load P, needed to fracture the 
five (5) tablets (n=5) were determined using the Monsanto hardness 
tester, the mean value was calculated and was used to calculate the 
tablet tensile strength (TS) from the equation: 
TS = 2P/πdt
Where P is the load required to crush the tablet, d is the diameter 
and t is the thickness of the tablet.
Statistical Analysis
The statistical analysis was conducted using IBM SPSS version 20. 
The One-way Analysis of Variance (ANOVA) was used followed by 
Dunnett’s test to compare the properties of modified starches of P. 
esculentus with MCC PH 101 in metronidazole tablet formulations. 
Significant differences among means were considered at 95% 
confidence level and p ≤ 0.05.
Results and Discussion 
Micromeritics and physicochemical characteristics
Angle of repose for the three modifications are presented in 
Table 2, the result revealed that they were all within theoretical limits 
for good flow of pharmaceutical powder [18]. On the other hand, 
the result for MCC PH 101 was 46.22 ± 0.250 indicating a poor flow. 
These results agree with the flow rates of these materials with MCC 
PH 101 having the lowest flow rate of 0.80 ± 0.02 g/s. From the results 
of angle of repose and flow rates, the flowability of these materials 
are ranked as follows; PPS > PPE > APS > MCC PH 101. The flow of 
powder during manufacturing predicts the quality of the final product 
in terms of weight and content uniformity [19]. Weight variation in 
tablets and ultimately content variation can be reduced to a minimum 
if the material possesses good flow property. For starch materials, such 
properties could be achieved by various modifications to affect the 
particle size and shapes [20].
Bulk and tapped densities are indirect measures of flow 
characteristics of powder, the values are also presented in Table 2. The 
values obtained were used to calculate the Hausner’s ratio and Carr’s 
index which also measure flowability of materials, and the values 
showed that for the modified starches, the Hausner’s ratios are within 
theoretical limit for fair flow characteristics 1.19 - 1.25, and Carr’s 
indices of PPE, PPS and APS respectively with all falling within range 
of 16-20% [13], indicating fair flow. For MCC PH 101, both the Carr’s 
index and Hausner’s ratio values indicated very poor flow [13]. This 
can be attributed to the inherent high cohesive nature of the MCC 
PH 101 which hindered its flowability. These could also be related to 
the particle size, shapes and particle size distribution of the materials 
because they all affect the flow of powder materials. Generally, as the 
values of these indices (Carr’s index and Hausner’s ratio) increases, the 
flow of powder decreases and this may lead to formulations problems 
like weight variation among others [13].
The bulk and tapped densities usually determine the die fill volume. 
Materials with higher bulk density require lower die fill volume than 
those having small bulk density [14]. From Table 2, it can be seen that 
MCC PH 101 has lower values both for bulk and tapped densities, 
indicating high die fill volume in comparison to those of the modified 
starches of P. esculentus. For the true density, the results are of the 
order APS>MCC PH 101>PPS>PPE. These results showed that true 
density is greater than the bulk density. Bulk density is always less than 
the true density of its component particles because the bulk powder 
contains interparticulate pores or interparticulate air-filled voids [13].
From the results of packing fraction and powder porosity in Table 
2, it can be said that PPE and PPS showed the highest maximum 
volume reduction followed by APS and MCC PH 101 having the least. 
Similarly, the porosity was in the order PPE<PPS<APS<MCC PH 101. 
MCC PH 101 has the highest porosity, indicating that the particles 
Parameter PPE PPS APS MCC PH101
Bulk Density (g/cm3) 0.66 ± 0.01 0.73 ± 0.02 0.64 ± 0.01 0.34 ± 0.00
Tapped Density (g/cm3) 0.78 ± 0.03 0.88 ± 0.03 0.78 ± 0.01 0.53 ± 0.01
True Density (g/cm3) 1.42 1.71 1.91 1.82
Angle of repose (0) 15.65 ± 0.91 25.43 ± 1.33 30.05 ± 1.2 46.22 ± 0.25
Flow Rate (g/s) 8.13 ± 0.09 8.25 ± 0.19 2.85 ± 0.17 0.80 ± 0.02
Carr’s Index (%) 15.63 ± 2.26 17.03 ±1.96 18.69 ± 2.03 35.38 ± 1.01
Hausner’s Ratio 1.18 ± 0.03 1.2 ± 0.03 1.23 ± 0.03 1.54 ± 0.03
Moisture Content (%) 13.40 11.00 8.80 7.00
Packing Fraction 0.46 0.43 0.34 0.19
Porosity (%) 54.00 57.00 66.00 81.00
pH 7.40 7.05 6.81 6.89
Mean Particle Size (µm) 68.20 ± 3.02 102.53 ± 3.98 13.53 ± 11.45 118.67 ± 8.11
Table 2: Micromeritics and Physicochemical Properties of Modified Starches of P. esculentus compared with MCC PH 101 (Mean ± SEM).
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are loosely packed, PPE on the other hand has the least porosity and 
therefore suggesting that its particles are more densely packed in 
comparison to PPS and APS.
For moisture contents, the BP 2009 [17] specifies that it should not 
exceed 15% for starch excipients. From the results obtained in Table 2, 
the values for all the materials are within the specified limit. Moisture 
level is also critical for solid dosage forms. Higher levels of moisture 
predict possible physical degradation and eventually it may lead to 
chemical decomposition as well as microbial contamination because 
moulds can easily grow in damp humid environment.
The pH values as shown in Table 2, for all the materials are within 
approximate neutral region, this finding indicate that when these 
materials are subjected to an aqueous medium, an acidic or alkaline 
medium will not result, which is particularly noteworthy when such 
products are to pass through the gastrointestinal tract.
The mean particle diameter from Table 2, are in the following 
rank APS<PPE<PPS<MCC PH 101. With the smaller mean particle 
diameter (size) of APS, it is expected to have improved packing in 
comparison to the rest with bigger particle size.
Dilution potential properties 
Table 3 shows the dilution capacity of the various materials. Dilution 
potential measures the amount of an API that can be satisfactorily 
compressed into tablets with the given directly compressible excipient. 
The data obtained were generated from crushing strength, friability 
and disintegration time of the solid compact of the drug and excipients 
in varying ratios. The results showed the following ranking MCC PH 
101>APS/PPE>PPS. The MCC PH 101 maintained superiority in terms 
of carrying capacity because it could accommodate up to 50% of the 
active drug, Apeji et al., made a similar finding [14]. From the modified 
starches, it was found that APS and PPE produced tablets with superior 
quality compared to PPS. But they are all within the range of 30-40% 
by weight, which is the range for a majority of directly compressible 
excipients [9,14].
Compaction and compressibility characteristics 
Figure 1 shows the Heckel plots of modified starches of P. esculentus 
and MCC PH 101. The mean yield pressure Py was calculated from the 
regions of the plots showing the highest correlation coefficient (r2 ≥ 
0.99) for all the formulations. The intercept A was determined from the 
extrapolation of the linear line. The values for Py, D0, DA, and DB for the 
formulations are presented in Table 4. The mean yield pressure, Py, is 
inversely related to the formulations ability to deform plastically under 
pressure [21,22]. The Py values showed that MCC PH 101 has the lowest 
while APS exhibited the highest. This indicates plastic deformation of 
these materials in the following order MCC PH 101 >PPE>PPS>APS. 
This means that MCC PH 101 is still superior in terms of plastic 
deformation in comparison to the various starches used in this study. 
The D0 value represents the degree of initial packing in the die because 
of die filling [23]. This result indicates that PPE exhibited a high degree 
of packing followed by PPS, with MCC PH 101 having the lowest 
initial packing. This could be related to the low bulk density of MCC 
PH 101. The DA values, which represent the total degree of packing at 
zero and low pressures, PPE was shown to have the highest value while 
MCC PH 101 exhibited the lowest DA value. The DB value represents 
the particle rearrangement phase in the early compression stages 
and tends to indicate the extent of particle or granule fragmentation, 
although fragmentation can occur concurrently with plastic and elastic 
deformation of constituent particles [22,24]. The DB values were PPS < 
MCC 101 <A PS < PPE. This indicates that PPE requires less pressure 
to undergo fragmentation and rearrangement while PPS may require 
higher pressure because it has the least DB value. 
Compressibility simply means the ability of a material to reduce 
in volume when compression pressure is applied to it [23]. A linear 
relationship exists between the density of tablets and the log of 
compaction pressure. The rate of increase of tablet density with 
increasing compaction pressure could be considered as an expression 
of compressibility [5,25]. The value of the slope of the plot of tablet 
density versus log of compression pressure is considered to express the 
compressibility index of a material, the bigger the value the better the 
compressibility of the material as reported by Walker, 1923 [5]. These 
values are shown in Table 5 as obtained from Figure 2. This result 
shows a comparable increase in density of tablets with an increase in 
compression pressure of MCC PH 101 with APS and PPS, but PPE 
exhibited the lowest value, indicating lower compressibility.
FTIR analysis
Figure 3 presents the comparative FTRI results, it compared the 
peaks generated from pure metronidazole alone and subsequent peaks 
obtained from the binary mix of the metronidazole and each of the 
modified starch developed. Metronidazole shows characteristics FTIR 
Material Drug/Excipient ratio (%)
MCC PH 101 50/50
APS 40/60
PPE 40/60
PPS 30/70
*Metronidazole was used as a model drug. Drug-carrying capacities (dilution 
potential) of modified starches of P. esculentus in comparison with MCC PH 101 
after evaluation of their crushing strengths, friability and disintegrations.
Table 3: Dilution potential of Modified starches of P. esculentus and MCC PH 101.
Material Py D0 DB DA
MCC PH 101 40.00 0.19 0.12 0.30
PPE 68.49 0.47 0.36 0.83
PPS 94.33 0.43 0.08 0.51
APS 133.33 0.34 0.18 0.52
*Py is the mean yield pressure; D0 is the relative density at zero pressure; DA 
is the relative density from the value of intercept A; DB describes the phase of 
rearrangement at low pressures (DA – D0).
Table 4: Parameters from Heckel plots used to evaluate the compaction and 
behaviours of modified starches of P. esculentus powders in comparison with MCC 
PH 101.
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Figure 1: Heckel plots for modified starches of P. esculentus and MCC PH 101 
of compact materials alone, the slope of which measure plastic deformation
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peaks at 3223.16 cm-1 (N-H stretching vibration), 1676.20 cm-1 (C 
= N stretching vibration), 1477.52 cm-1 (C = C aromatic ring stretch 
vibration), 3223.16 cm-1 (O-H bonded vibration), 1423.51 cm-1 (-CH3 
bending vibration), 1327.07 cm-1 (C-N stretch vibration), 1211.34 cm-1 
(C-O stretch vibration), 754.19 cm-1 (C-H bending vibration aromatic) 
and 1423.51 cm-1 (N = O stretching vibration). Furthermore, the spectra 
obtained from the physical mixture of the pure drug and the excipients 
Figure 3 showed mere superimpositions of that of the pure drug alone. 
This indicates that there was no chemical interaction between the drug 
and excipients used. FTIR spectroscopy is an important tool used to 
assess the interaction between excipients and guest molecules in the 
solid state which can be revealed as shifts disappearances or changes in 
the absorption spectrum of the API [2,21].
Physical evaluation of tablets
Crushing strength and tensile strength are indices used to 
measure the hardness of a tablet. Although there is no official limit for 
tablet hardness, values fall within the range of 40 - 78 N are generally 
acceptable for uncoated tablets [26]. From Table 5, it was shown that 
the hardness of metronidazole tablets formulated from PPE, APS and 
MCC PH 101 were high and are in the range of 64.30 - 79.43 N, these 
are within the acceptable limits. The values for PPS, however, was 
significantly low 28.44 N, this does not meet the required standard. It 
can also be noted from Table 6 that the values for tensile strengths for 
these formulations also followed a similar pattern. This implies that 
formulations with PPE, APS and MCC PH 101 are likely to withstand 
the harsh conditions of packaging, dispensing and transportation. 
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Figure 2: Plots of tablet compact densities of modified starches of P. esculentus and MCC PH 101 against log of compaction pressure
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Figure 3: Overlay of comparative FTIR spectra of pure drug and physical mixture of drug and modified starches of P. esculentus.
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On the other hand, a formulation with PPS fails to meet these 
requirements.
Friability is inversely related to tablets crushing strength and it 
measures the tablet softness to wear and tear. The lower the friability 
value the better the tablet withstands mechanical handling. Weight 
loss due to friability from formulations containing PPE, APS and MCC 
PH 101 all fell below 1% Table 5. MCC PH 101 and the two modified 
starches (PPE and APS) agrees with the findings of Apeji et al., [14]. 
Friability value for PPS, on the other hand, fails to meet the standard as 
the value was much higher 8.74%, this can be related to its low dilution 
potential observed. 
Tablets thickness and diameter values are shown in Table 6, and 
the result revealed that there was no significant variation in their mean 
values. Addition of lubricant (stearic acid) and glidant (talc) must 
have prevented the die wall friction and enhanced the flow of powder 
blend respectively. This ensured uniform volume of the powder blend 
to be fed into the die cavity resulting in uniform tablets diameter and 
thickness. 
Tablet disintegration test 
From Table 6, APS and PPS disintegrate faster 2.83 and 1.42 
min, respectively, which was significantly different p=0.01 from the 
disintegration time of tablets containing MCC PH 101 and PPE. 
Fast disintegration for starches and their use as tablets disintegrants 
have been documented [27]. On the other hand, the values for tablets 
containing MCC PH 101 and PPE were higher 35.34 and 45.53 min 
respectively. This could be attributed to the high hardness of both 
Material Drug/Excipient ratio (%)
MCC PH 101 0.99
PPE 0.48
PPS 0.50
APS 0.60
slope generated from the plots of tablet compact densities against the log of compaction pressure which revealed the compressibility indices of modified starches of P. 
esaculentus in comparison with MCC PH 101.
Table 5: Compressibility index of modified starches of P. esculentus and MCC PH 101.
Parameter MCC PH 101 PPE PPS APS P value*
Mean tablet weight 553 ± 3.65 553.5 ± 1.86 532.5 ± 1.80 553.5 ± 3.18
Thickness (mm) 4.67 ± 0.01 4.44 ± 0.02 4.41 ± 0.03 4.46 ± 0.03
Diameter (mm) 12.09 ± 0.01 12.04 ± 0.01 12.17 ± 0.02 12.09 ± 0.01
Friability (%) 0.72 0.54 8.74 0.90
Crushing strength (N) 64.3 ± 0.41 79.43 ± 0.32 79.43 ± 0.32 70.41 ± 0.55
Tensile strength (MNm-2) 0.73 0.95 0.03 0.83
Disintegration time (min) 35.34 ± 4.33 45.53 ± 3.11 1.42 ± 0.19 2.83 ± 2.11 0.01
T50% (min) - 38.00 2.30 3.40
T90% (min) - 58.00 3.40 5.15
Content uniformity (%) 95.33 ± 3.04 102.12 ± 2.11 96.81 ± 3.12 104.05 ± 4.01
*ANOVA, T90% (min) is the time taken to release 90 % of the active drug from the tablet, T50% (min) is the time taken to release 50% of the drug from the tablet
Table 6: Physicochemical and quality control Properties of Tablets formulated from Modified Starches of P. esculentus compared with MCC PH 101 (Mean ± Standard 
Error of Mean).
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Figure 4: The cumulative in-vitro dissolution profile of metronidazole 200 mg tablets formulated with modified starches of P. esculentus and MCC PH 101 with T50 
and T90 evaluated.
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can be substituted for MCC PH 101 in DC for immediate release tablet 
formulations.
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materials (>60 N). However, for PPE, it was observed that it forms a 
sticky jelly in contact with water, this can prevent water penetration into 
the tablets during disintegration and hence could explain the reason 
why it disintegrates more slowly. MCC PH 101 and PPE, therefore, do 
not pass the official limit for disintegration (<15 minutes). Conversely, 
tablets containing APS and PPS both disintegrate within the official 
specification set by B.P. Rapid disintegration is one of the advantages 
of tablets produced by the direct compression method. 
In vitro dissolution profiles
The dissolution profiles for metronidazole tablet formulations are 
shown in Figure 4 and data were generated are presented in Table 6. 
The T50 and T90 for MCC PH 101 and modified starches of P. esculentus 
formulations were evaluated from the profile. Tablets formulated 
with APS and PPS, both the T50 and T90 were achieved in less than 10 
minutes, with a significant difference at, this directly revealed that 75% 
of the active drug was released from these two formulations in less than 
45 minutes as specified by BP for immediate release tablets. Therefore, 
these formulations (4.8 minutes and 4.0 minutes respectively) are said 
to comply with the BP specification. On the other hand, the T50 and 
T90 for PPE were achieved at 38 and 58 minutes respectively, while for 
MCC PH 101 both T50 and T90 were not attained after 60 minutes. MCC 
PH 101 and PPE batches did not comply with the BP specification for 
dissolution. However, it can also be seen that the dissolution pattern for 
all the formulations relates to their respective disintegration scenario. 
In vitro dissolution rate affects the solubility of a drug molecule 
within the formulated tablet and consequently in vivo absorption 
and bioavailability of drugs. Thus, in vitro dissolution study plays an 
important role in the in vivo performance of tablets dosage form [28].
Tablet content uniformity
The official requirement for content uniformity of active ingredient 
is met if the percentage content of tablets with average weight above 
250 mg falls within 95-105% (USP and BP). The mean average content 
of analyzed metronidazole tablets formulated from MCC PH 101 and 
modified starches of P. esculentus was found to be in the range of 95.33 
- 104.05% (Table 6). All the tablets meet the pharmacopoeias limit for 
the content uniformity test. 
Tablet weight uniformity 
Weight uniformity test for tablets is required to ensure that the 
drug content in each tablet is distributed in a narrow range around the 
labelled strength because a slight variation in weight of tablet reflects 
variation in the content of active ingredient. The USP specified that for 
a drug product whose weight is above 324 mg, the allowed limit of ± 
5% of the average is required to pass the weight uniformity test. From 
Table 6, the result shows that all the formulations passed the official 
acceptable limit for uniformity of weight (mean ± 5%). 
Conclusion 
The FTIR revealed no interaction of Plecthantus esculentus 
modified starches developed with the metronidazole, indicating 
their safety for use in pharmaceutical formulations. The compaction 
studies highlighted comparable plastic deformation behaviors of APS 
and PPE with MCC PH 101 indicating their ability to remain as solid 
compact after powder compression pressure withdrawal. Based on 
the in vitro dissolution profile and other quality control parameters 
obtained, metronidazole tablets formulated with APS were observed 
to have good quality characteristics. Therefore, acid hydrolysis of P. 
esculentus starch produced a good directly compressible excipient that 
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